Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BBOX1 | O75936 | 2/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 4/20 | 0.45 |
| ▸ | APOBEC3A | P31941 | 2/20 | 0.45 |
| ▸ | APOBEC3G | Q9HC16 | 2/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.45 |
| ▸ | BLM | P54132 | 1/20 | 0.45 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.45 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.41 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.41 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.41 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.41 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.41 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.37 |
| ▸ | CHRNA7 | P36544 | 3/20 | 0.37 |
| ▸ | CHRNB2 | P17787 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL8910745 | 0.97 | BBOX1 (0.56) | BBOX1KDM4ELMNAAPOBEC3AAPOBEC3G | |
| SCHEMBL7166850 | 0.97 | BBOX1 (0.56) | BBOX1KDM4ELMNAAPOBEC3AAPOBEC3G | |
| SCHEMBL812356 | 0.93 | BBOX1 (0.58) | BBOX1KDM4ELMNAAPOBEC3AAPOBEC3G | |
| SCHEMBL12638424 | 0.90 | BBOX1 (0.56) | BBOX1KDM4ELMNAAPOBEC3AAPOBEC3G | |
| Bromide SCHEMBL7628516 | 0.90 | BBOX1 (0.56) | BBOX1KDM4ELMNAAPOBEC3AAPOBEC3G | |
| Water SCHEMBL20472801 | 0.90 | BBOX1 (0.56) | BBOX1KDM4ELMNAAPOBEC3AAPOBEC3G | |
| Pentolinium SCHEMBL210048 | 0.90 | BBOX1 (0.56) | BBOX1KDM4ELMNAAPOBEC3AAPOBEC3G | |
| SCHEMBL7593954 | 0.90 | BBOX1 (0.56) | BBOX1KDM4ELMNAAPOBEC3AAPOBEC3G | |
| SCHEMBL2158184 | 0.90 | BBOX1 (0.56) | BBOX1KDM4ELMNAAPOBEC3AAPOBEC3G | |
| SCHEMBL2393255 | 0.90 | BBOX1 (0.56) | BBOX1KDM4ELMNAAPOBEC3AAPOBEC3G |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3204977-B1 | ELECTROLYTE FOR RECHARGEABLE ELECTROCHEMICAL CELL | EOS ENERGY TECH HOLDINGS LLC (US) | 2023-12-20 | — | — | EP | claimed |
| US-11043701-B2 | Zinc-halide battery using a deep eutectic solvent-based electrolyte | EOS ENERGY STORAGE LLC (US) | 2021-06-22 | — | — | US | claimed |
| EP-3459137-A2 | ZINC-HALIDE BATTERY USING A DEEP EUTECTIC SOLVENT-BASED ELECTROLYTE | Eos Energy Storage, LLC (US) | 2019-03-27 | — | — | EP | claimed |
| US-11942606-B2 | Electrolyte for rechargeable electrochemical cell | EOS Energy Technology Holdings, LLC (US) | 2024-03-26 | — | — | US | disclosed |
| US-11728520-B2 | Zinc-halide battery using a deep eutectic solvent-based electrolyte | EOS Energy Technology Holdings, LLC (US) | 2023-08-15 | — | — | US | disclosed |
| CN-108290749-B | Novel synthetic crystalline EMM-28 material, its preparation and use | 埃克森美孚科技工程公司 | 2022-06-24 | — | — | CN | disclosed |
| CN-114566723-A | Electrolyte for rechargeable electrochemical cells | EOS能源储存有限责任公司 | 2022-05-31 | — | — | CN | disclosed |
| CN-109155444-B | Electrolyte for rechargeable electrochemical cells | EOS能源储存有限责任公司 | 2022-03-25 | — | — | CN | disclosed |
| US-20210344050-A1 | ZINC-HALIDE BATTERY USING A DEEP EUTECTIC SOLVENT-BASED ELECTROLYTE | CITIBANK, N.A., AS COLLATERAL AGENT | 2021-11-04 | — | — | US | disclosed |
| US-11043701-B2 | Zinc-halide battery using a deep eutectic solvent-based electrolyte | EOS ENERGY STORAGE LLC (US) | 2021-06-22 | — | — | US | disclosed |
| US-20210119265-A1 | ELECTROLYTE FOR RECHARGEABLE ELECTROCHEMICAL CELL | EOS ENERGY STORAGE, LLC (US) | 2021-04-22 | — | — | US | disclosed |
| US-8182581-B2 | use of these novel bis-cationic and/or bis-anionic ionic liquids as the stationary phase in a gas chromatographic column | SIGMA-ALDRICH CO. LLC (US) | 2012-05-22 | — | — | US | disclosed |
| US-20120111796-A1 | Boron Selective Ionic Liquids and Polymeric Ionic Liquids, Methods of Making and Methods of Use Thereof | UNIVERSITY OF TOLEDO (US) | 2012-05-10 | — | — | US | disclosed |
| US-8168830-B2 | use of these novel ionic liquids having bis-cation or bis-anion separated by bridging group as the stationary phase in a gas chromatographic column | SIGMA-ALDRICH CO. LLC (US) | 2012-05-01 | — | — | US | disclosed |
| US-20110236295-A1 | Polymeric Ionic Liquids, Methods of Making and Methods of Use Thereof | UNIVERSITY OF TOLEDO (US) | 2011-09-29 | — | — | US | disclosed |
| US-20110236295-A1 | Polymeric Ionic Liquids, Methods of Making and Methods of Use Thereof | UNIVERSITY OF TOLEDO (US) | 2011-09-29 | — | — | US | disclosed |
| WO-2010017563-A1 | POLYMERIC IONIC LIQUIDS, METHODS OF MAKING AND METHODS OF USE THEREOF | UNIVERSITY OF TOLEDO (US) | 2010-02-11 | — | — | WO | disclosed |
| WO-2010017564-A1 | BORON SELECTIVE IONIC LIQUIDS AND POLYMERIC IONIC LIQUIDS, METHODS OF MAKING AND METHODS OF USE THEREOF | UNIVERSITY OF TOLEDO (US) | 2010-02-11 | — | — | WO | disclosed |
| US-20080027231-A1 | High stability diionic liquid salts | SIGMA-ALDRICH CO. (US) | 2008-01-31 | — | — | US | disclosed |
| US-20060025598-A1 | High stability diionic liquid salts | ADVANCED SEPARATION TECHNOLOGIES INC. (US) | 2006-02-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080027231-A1 | High stability diionic liquid salts | H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, HDHD5, DAD1 | BBOX1 4134/4885KDM4E 4578/4885LMNA 739/4885 |
| US-20060025598-A1 | High stability diionic liquid salts | H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, DCLK2, HDHD5 | BBOX1 4186/4885KDM4E 4458/4885LMNA 671/4885 |
| US-20120111796-A1 | Boron Selective Ionic Liquids and Polymeric Ionic Liquids, Methods of Making and Methods of Use Thereof | BCCIP, SLC6A12, BOLA2; BOLA2B | BBOX1 446/4885KDM4E 3850/4885LMNA 584/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.